Drug profile · INN
tamsulosin hydrochloride
FLOMAX
tamsulosin hydrochloride (FLOMAX) is a adrenergic receptor alpha-1 antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — tamsulosin hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 3
- Data quality
- 0.89
Quick answer
tamsulosin hydrochloride (FLOMAX) is a adrenergic receptor alpha-1 antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Adrenergic receptor alpha-1 antagonist
Primary target: Adrenergic receptor alpha-1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is tamsulosin hydrochloride?
tamsulosin hydrochloride (FLOMAX) is a adrenergic receptor alpha-1 antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for tamsulosin hydrochloride?
FLOMAX is a marketed brand name for tamsulosin hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tamsulosin hydrochloride?
tamsulosin hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.